BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND FOXA1, TCF3A, 3169, ENSG00000129514, P55317, HNF3A, MGC33105 AND Treatment
7 results:

  • 1. [miR-485-3p and miR-4728-5p as Tumor Suppressors in Pathogenesis of colorectal cancer].
    Gurer T; Aytekin A; Caki E; Gezici S
    Mol Biol (Mosk); 2022; 56(3):516-520. PubMed ID: 35621109
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Histopathological and genetic features of mismatch repair-deficient high-grade prostate cancer.
    Wyvekens N; Tsai HK; Sholl LM; Tucci J; Giannico GA; Gordetsky JB; Hirsch MS; Barletta JA; Acosta AM
    Histopathology; 2022 Jun; 80(7):1050-1060. PubMed ID: 35395112
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. foxa1-induced LINC01207 facilitates head and neck squamous cell carcinoma via up-regulation of TNRC6B.
    Chen C; Jiang L; Zhang Y; Zheng W
    Biomed Pharmacother; 2020 Aug; 128():110220. PubMed ID: 32450521
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. MicroRNA-760 inhibits the biological progression of colorectal carcinoma by directly targeting foxa1 and regulating epithelial-to-mesenchymal transition and PI3K/AKT signaling pathway.
    Cong K; Li CG; Wei YH; Zhang K; Xu HB
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5730-5740. PubMed ID: 31298352
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Aberrant activation of CYR61 enhancers in colorectal cancer development.
    Xie L; Song X; Lin H; Chen Z; Li Q; Guo T; Xu T; Su T; Xu M; Chang X; Wang LK; Liang B; Huang D
    J Exp Clin Cancer Res; 2019 May; 38(1):213. PubMed ID: 31118064
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Phase I/II study of oxaliplatin with oral S-1 as first-line therapy for patients with metastatic colorectal cancer.
    Yamada Y; Tahara M; Miya T; Satoh T; Shirao K; Shimada Y; Ohtsu A; Sasaki Y; Tanigawara Y
    Br J Cancer; 2008 Mar; 98(6):1034-8. PubMed ID: 18319719
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer.
    Bujko K; Nowacki MP; Nasierowska-Guttmejer A; Michalski W; Bebenek M; Kryj M
    Br J Surg; 2006 Oct; 93(10):1215-23. PubMed ID: 16983741
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.